Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administered Infanrix to a 12-year old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-year-old patient who received DTPa (Infanrix) for prophylaxis. On 22-APR-2025, the patient received Infanrix. On 22-APR-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: administered Infanrix to a 12-year old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-APR-2025 The reporter reported that he/she administered Infanrix to a 12-year-old patient, which led to Inappropriate age at vaccine administration. The Vaccine Administration Facility is the same as Primary Reporter.